AlphaYouDM
Insider selling
David Malcom Rodman sold $66K of Mineralys Therapeutics, Inc. (MLYS) stock
David Malcom Rodman, Chief Medical Officer of Mineralys Therapeutics, Inc. (MLYS), sold 2,171 shares of MLYS stock worth $66K, per an SEC Form 4 filed Jul 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 9, 2026, 1 day before it was made public.
MLYS has moved -2.2% since the trade date, from $28.96 to $28.31 (Sep 21, 2026 close).
- Traded
- Jul 9, 2026
- Disclosed
- Jul 10, 2026
- Filing delay
- 1 day
- Price since
- -2.2%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More MLYS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.